TABLE 4

Individual and mean plasma and brain concentrations and some basic pharmacokinetic parameters after single subcutaneous administration at 40 mg/kg of JNJ-1930942 in male Swiss mouse

Three male Swiss mice (numbered 1–3) received a single dose of 40 mg/kg s.c. JNJ-1930942. Plasma and brain samples were collected at different time intervals after compound administration. Concentrations of JNJ-1930942 were determined as described under Materials and Methods and plotted as a function of time.

JNJ-1930942
PlasmaBrain
123Mean ± SD123Mean ± SD
ng/mlng/g
Time
    0.5 h5260773047705920 ± 15872330200014101913 ± 466
    1 h2780377025703040 ± 64189320709941319 ± 652
    2 h1170178021201690 ± 481363448560457 ± 99
    4 h167247115176 ± 6660.672.345.459.4 ± 13.5
    8 h14.692.528.945.3 ± 41.510.524.111.415.3 ± 7.6
Cmax (ng/ml)59201913
Tmax (h)0.50.5
t1/2 (4–8 h) (h)2.02.0
AUC0–8 h (ng · h · ml−1)76642610
AUC (ng · h · ml−1)77972655
Brain-to-plasma ratio0.3